Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Post-SELEX optimization of aptamers.

Gao S, Zheng X, Jiao B, Wang L.

Anal Bioanal Chem. 2016 Jul;408(17):4567-73. doi: 10.1007/s00216-016-9556-2. Epub 2016 May 12. Review.

PMID:
27173394
2.

Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials.

Oellers P, Grewal DS, Fekrat S.

Clin Ophthalmol. 2016 Mar 8;10:411-8. doi: 10.2147/OPTH.S98853. eCollection 2016. Review.

4.

Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.

Sankar MJ, Sankar J, Mehta M, Bhat V, Srinivasan R.

Cochrane Database Syst Rev. 2016;2:CD009734. doi: 10.1002/14651858.CD009734.pub2. Epub 2016 Feb 27. Review.

PMID:
26932750
5.

Patient Preferences in the Treatment of Neovascular Age-Related Macular Degeneration: A Discrete Choice Experiment.

Mueller S, Agostini H, Ehlken C, Bauer-Steinhusen U, Hasanbasic Z, Wilke T.

Ophthalmology. 2016 Apr;123(4):876-83. doi: 10.1016/j.ophtha.2015.12.001. Epub 2016 Jan 14.

PMID:
26778346
6.

ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY: A Systematic Review and Meta-Analysis.

Simunovic MP, Maberley DA.

Retina. 2015 Oct;35(10):1931-42. doi: 10.1097/IAE.0000000000000723. Review.

PMID:
26398553
7.

Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application.

Zhang Y, Han Q, Ru Y, Bo Q, Wei RH.

Drug Des Devel Ther. 2015 Jul 2;9:3413-21. doi: 10.2147/DDDT.S87920. eCollection 2015. Review.

8.

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.

Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I, Pijoán JI, Buil-Calvo JA, Cordero JA, Evans JR.

Cochrane Database Syst Rev. 2014 Nov 24;(11):CD008721. doi: 10.1002/14651858.CD008721.pub2. Review.

PMID:
25418485
9.

Measuring Health-Related Quality of Life for Patients with Diabetic Retinopathy [Internet].

Milne A, Johnson JA, Tennant M, Rudnisky C, Dryden DM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Apr 23.

10.

Anti-vascular endothelial growth factor for diabetic macular oedema.

Virgili G, Parravano M, Menchini F, Evans JR.

Cochrane Database Syst Rev. 2014 Oct 24;(10):CD007419. doi: 10.1002/14651858.CD007419.pub4. Review.

PMID:
25342124
11.

Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS.

Cochrane Database Syst Rev. 2014 Aug 29;(8):CD005139. doi: 10.1002/14651858.CD005139.pub3. Review.

12.
13.

Safety monitoring of ophthalmic biologics: a systematic review of pre- and postmarketing safety data.

Penedones A, Mendes D, Alves C, Batel Marques F.

J Ocul Pharmacol Ther. 2014 Nov;30(9):729-51. doi: 10.1089/jop.2013.0206. Epub 2014 Jul 29. Review.

PMID:
25073069
14.

Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.

Braithwaite T, Nanji AA, Lindsley K, Greenberg PB.

Cochrane Database Syst Rev. 2014 May 1;(5):CD007325. doi: 10.1002/14651858.CD007325.pub3. Review.

15.
16.

Treatments for macular oedema following central retinal vein occlusion: systematic review.

Ford JA, Clar C, Lois N, Barton S, Thomas S, Court R, Shyangdan D, Waugh N.

BMJ Open. 2014 Feb 10;4(2):e004120. doi: 10.1136/bmjopen-2013-004120. Review.

17.

Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis.

Zhou S, Gao J, Xu X.

Clin Experiment Ophthalmol. 2014 Sep-Oct;42(7):637-49. doi: 10.1111/ceo.12286. Epub 2014 Jan 27.

PMID:
24330277
18.

Management paradigms for diabetic macular edema.

Mitchell P, Wong TY; Diabetic Macular Edema Treatment Guideline Working Group.

Am J Ophthalmol. 2014 Mar;157(3):505-13.e1-8. doi: 10.1016/j.ajo.2013.11.012. Epub 2013 Nov 19.

PMID:
24269850
19.

Critical appraisal of ranibizumab in the treatment of diabetic macular edema.

Stewart MW.

Clin Ophthalmol. 2013;7:1257-67. doi: 10.2147/OPTH.S36443. Epub 2013 Jun 24.

20.

Current treatments in diabetic macular oedema: systematic review and meta-analysis.

Ford JA, Lois N, Royle P, Clar C, Shyangdan D, Waugh N.

BMJ Open. 2013 Mar 1;3(3). pii: e002269. doi: 10.1136/bmjopen-2012-002269.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk